home / stock / lvtx / lvtx short
Short Information | LAVA Therapeutics N.V. (NASDAQ:LVTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 294,832 |
Total Actual Volume | 1,779,673 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 14,742 |
Average Short Percentage | 15.03% |
Is there a LVTX Short Squeeze or Breakout about to happen?
See the LVTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $2.04 | $2.06 | $2.1299 | $2.01 | 33,629 | 1,723 | 5.12% |
07-18-2024 | $2.32 | $2.075 | $2.32 | $2.001 | 71,688 | 13,176 | 18.38% |
07-17-2024 | $2.17 | $2.29 | $2.39 | $2.1248 | 181,575 | 38,734 | 21.33% |
07-16-2024 | $1.78 | $2.11 | $2.22 | $1.78 | 433,212 | 86,224 | 19.9% |
07-15-2024 | $1.91 | $1.8 | $1.91 | $1.72 | 123,823 | 16,755 | 13.53% |
07-12-2024 | $1.78 | $1.87 | $1.89 | $1.78 | 46,507 | 7,528 | 16.19% |
07-11-2024 | $1.91 | $1.79 | $1.98 | $1.78 | 101,587 | 7,904 | 7.78% |
07-10-2024 | $1.91 | $1.91 | $1.9472 | $1.86 | 52,251 | 6,870 | 13.15% |
07-09-2024 | $1.89 | $1.89 | $1.9 | $1.8 | 29,714 | 2,146 | 7.22% |
07-08-2024 | $1.97 | $1.85 | $2.0246 | $1.85 | 51,630 | 9,994 | 19.36% |
07-05-2024 | $1.8 | $1.89 | $1.93 | $1.8 | 78,248 | 13,929 | 17.8% |
07-03-2024 | $1.88 | $1.8 | $1.94 | $1.79 | 41,916 | 2,801 | 6.68% |
07-02-2024 | $1.8501 | $1.89 | $2.0199 | $1.8501 | 53,151 | 15,743 | 29.62% |
07-01-2024 | $1.84 | $1.87 | $2.06 | $1.83 | 18,430 | 4,165 | 22.6% |
06-28-2024 | $1.95 | $1.8 | $2.06 | $1.8 | 89,709 | 9,109 | 10.15% |
06-27-2024 | $1.86 | $1.88 | $2.0256 | $1.82 | 102,355 | 24,753 | 24.18% |
06-26-2024 | $1.89 | $1.85 | $2.04 | $1.84 | 67,484 | 11,597 | 17.18% |
06-25-2024 | $1.8701 | $1.94 | $2.11 | $1.85 | 110,675 | 12,850 | 11.61% |
06-24-2024 | $1.929 | $1.87 | $1.96 | $1.8501 | 41,974 | 3,351 | 7.98% |
06-21-2024 | $1.9 | $1.86 | $1.99 | $1.81 | 50,115 | 5,480 | 10.93% |
News, Short Squeeze, Breakout and More Instantly...
LAVA Therapeutics N.V. Company Name:
LVTX Stock Symbol:
NASDAQ Market:
LAVA Therapeutics N.V. Website:
UTRECHT, The Netherlands and PHILADELPHIA, June 20, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody ® platform of bispecific gamma delta T cell eng...
UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” or “Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamm...
LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1 LAVA-1266 on track for Q2 2024 IND sub...